CHEMM.CO
Price:
$432.6
Market Cap:
$7.53B
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCount...[Read more]
Industry
Medical - Devices
IPO Date
2006-12-18
Stock Exchange
CPH
Ticker
CHEMM.CO
According to ChemoMetec A/S’s latest financial reports and current stock price. The company's current PE Ratio is 55.39. This represents a change of 137.89% compared to the average of 23.28 of the last 4 quarters.
The mean historical PE Ratio of ChemoMetec A/S over the last ten years is 64.75. The current 55.39 PE Ratio has changed 8.45% with respect to the historical average. Over the past ten years (40 quarters), CHEMM.CO's PE Ratio was at its highest in in the September 2016 quarter at 136.15. The PE Ratio was at its lowest in in the June 2014 quarter at -252.02.
Average
64.75
Median
55.47
Minimum
0
Maximum
166.14
Discovering the peaks and valleys of ChemoMetec A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 85.10%
Maximum Annual PE Ratio = 166.14
Minimum Annual Increase = -100.00%
Minimum Annual PE Ratio = 0
Year | PE Ratio | Change |
---|---|---|
2024 | 0 | -100.00% |
2023 | 45.39 | -45.06% |
2022 | 82.61 | -50.28% |
2021 | 166.14 | 85.10% |
2020 | 89.75 | 52.21% |
2019 | 58.97 | 13.48% |
2018 | 51.96 | -23.62% |
2017 | 68.03 | 34.65% |
2016 | 50.52 | 48.13% |
2015 | 34.11 | -39.78% |
The current PE Ratio of ChemoMetec A/S (CHEMM.CO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
42.67
5-year avg
76.78
10-year avg
64.75
ChemoMetec A/S’s PE Ratio is greater than cBrain A/S (38.05), less than Ambu A/S (79.24), greater than Genmab A/S (20.43), greater than Zealand Pharma A/S (-80.65), less than ALK-Abelló A/S (58.12),
Company | PE Ratio | Market cap |
---|---|---|
38.05 | $4.13B | |
79.24 | $36.07B | |
20.43 | $110.79B | |
-80.65 | $64.98B | |
58.12 | $39.56B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ChemoMetec A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ChemoMetec A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ChemoMetec A/S's PE Ratio?
How is the PE Ratio calculated for ChemoMetec A/S (CHEMM.CO)?
What is the highest PE Ratio for ChemoMetec A/S (CHEMM.CO)?
What is the 3-year average PE Ratio for ChemoMetec A/S (CHEMM.CO)?
What is the 5-year average PE Ratio for ChemoMetec A/S (CHEMM.CO)?
How does the current PE Ratio for ChemoMetec A/S (CHEMM.CO) compare to its historical average?